Duncan McHale

Currently holds a position at Evelo Biosciences Inc

Position	Company	Period
Chief Medical Officer	Evelo Biosciences Inc	Feb. 1, 2018 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2023-11-08	2023-11-08	Evelo Biosciences Inc (EVLO)	PS Planned sale	3,103 -15.4% 0.33 USD 1,024	3,103 -15.4%	0.33	USD 1,024
2023-11-03	2023-11-02	Evelo Biosciences Inc (EVLO)	PS Planned sale	6,854 -33.5% 0.33 USD 2,262	6,854 -33.5%	0.33	USD 2,262
2023-08-09	2023-08-08	Evelo Biosciences Inc (EVLO)	PS Planned sale	3,434 -30.2% 9.51 USD 32,657	3,434 -30.2%	9.51	USD 32,657
2023-05-10	2023-05-08	Evelo Biosciences Inc (EVLO)	PS Planned sale	66,730 -40.6% 0.13 USD 8,375	66,730 -40.6%	0.13	USD 8,375
2022-05-31	2022-05-27	Evelo Biosciences Inc (EVLO)	B Purchase	34,246 +inf% 1.46 USD 49,999	34,246 +inf%	1.46	USD 49,999